The Efficacy and Safety of Diluted Oral Phosphate Enema Versus Intravenous Sodium Glycerophosphate in the Treatment of Hypophosphatemia in ICU Patients

Last updated: October 19, 2024
Sponsor: Ain Shams University
Overall Status: Active - Recruiting

Phase

2/3

Condition

N/A

Treatment

Enema Phosphates Sodium

Glycophos Injectable Product

Clinical Study ID

NCT06651892
REC #270
  • Ages > 18
  • All Genders

Study Summary

The goal of this clinical trial is to study the efficacy and safety of diluted phosphate enema in treating hypophosphatemia in adults in critical care unit in comparison to intravenous sodium glycero-phosphate as the current standard of care.

The main question it aims to answer is:

can the investigators rely on phosphate enemas as an effective and safe treatment option for hypophosphatemia in critically ill adults, in the era of global shortage of parenteral nutrition solutions and the absence of defined guidelines for treatment of acute hypophosphatemia in those population.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Critically ill Patients with mild (2-2.4 mg/dl) to moderate (1.5-1.9 mg/dl)hypophosphatemia.

  • Serum phosphorus level less than 2.5mg/dl - between 1.5 - 2.5mg/dl

  • Patients 18 years or older

Exclusion

Exclusion Criteria:

  • Severe hypophosphatemia

  • Serum Phosphorus level less than 1.5 mg/dL

  • Patients on Non-peroral status

  • Ileus (as paralytic ileus, post-operative)

  • Any problem in gut integrity as (intestinal obstruction, Severe Malabsorption,severe diarrhea)

  • Any form of ischemic gut (as mesenteric ischemia, mesenteric gastric occlusion,arterial venous insufficiency)

  • Hemodynamically unstable patients

  • Severe Hypocalcemia or Hypercalcemia at the beginning of the study (when ivphosphate is deemed inappropriate at the discretion of attending physician)

Study Design

Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Enema Phosphates Sodium
Phase: 2/3
Study Start date:
May 01, 2024
Estimated Completion Date:
December 30, 2024

Study Description

A Randomized Controlled Trial - Non inferiority trial of 2 groups, Eligible participants will be randomly assigned to one of two groups (Intervention Group will receive Diluted Oral phosphate enema as the repletion strategy, while Control Group will receive The Standard of care: intravenous sodium glycerophosphate) for the purpose of treatment of hypophosphatemia in critically ill patients.

Dose Calculation: as per hospital protocol and scientific reference(Crook, 2009) 0.32 mmol per kg for mild hypophosphatemia 0.64 mmol per kg for moderate hypophosphatemia

All participants will be reassessed the next day after the intervention and followed up for the occurrence of any side effects, then participants will be followed up again the day after. (Assessment of serum phosphate and sodium along with occurrence of diarrhea or any other side effects).

Connect with a study center

  • Al haram Hospital

    Giza,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.